| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |